5-65763017-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020726.5(NLN):c.359C>A(p.Ala120Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020726.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NLN | NM_020726.5 | c.359C>A | p.Ala120Glu | missense_variant | 3/13 | ENST00000380985.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NLN | ENST00000380985.10 | c.359C>A | p.Ala120Glu | missense_variant | 3/13 | 1 | NM_020726.5 | P1 | |
NLN | ENST00000506539.5 | n.475C>A | non_coding_transcript_exon_variant | 3/9 | 1 | ||||
NLN | ENST00000502464.5 | c.47C>A | p.Ala16Glu | missense_variant | 2/12 | 5 | |||
NLN | ENST00000514991.5 | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250944Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135596
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461636Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 727146
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74264
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.359C>A (p.A120E) alteration is located in exon 3 (coding exon 3) of the NLN gene. This alteration results from a C to A substitution at nucleotide position 359, causing the alanine (A) at amino acid position 120 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at